30 July 2008
THE BIOTECH GROWTH TRUST PLC
(the "Company")
ANNUAL INFORMATION UPDATE
For the 12 months ending Wednesday, 30 July 2008
In accordance with the Prospectus Rule 5.2, the Company reports upon
information that it has published or made available to the public over the 12
months ending on 30 July 2008.
In accordance with PR5.2.7 some of the announcements during the year may relate
to matters which have subsequently changed since the original announcement.
Company Announcements
With the exception of the daily net asset value announcements, the Company has
made the following announcements through PR Newswire (PRN):
Date of Publication Summary Description Method of Publication
29 July 2008 Annual Report & Accounts PRN
28 July 2008 AGM Statement PRN
11 July 2008 Transaction in own shares PRN
8 July 2008 Transaction in own shares PRN
1 July 2008 Total voting rights PRN
26 June 2008 Transaction in own shares PRN
24 June 2008 Annual Report & Accounts PRN
20 June 2008 Transaction in own shares PRN
13 June 2008 Final Results PRN
2 June 2008 Total voting rights PRN
2 June 2008 Transaction in own shares PRN
23 May 2008 Transaction in own shares PRN
16 May 2008 Transaction in own shares PRN
9 May 2008 Transaction in own shares PRN
2 May 2008 Transaction in own shares PRN
18 April 2008 Transaction in own shares PRN
11 April 2008 Transaction in own shares PRN
7 April 2008 Holdings in Company PRN
3 April 2008 Transaction in own shares PRN
2 April 2008 Total voting rights PRN
1 April 2008 Compliance with Model Code PRN
28 March 2008 Transaction in own shares PRN
20 March 2008 Transaction in own shares PRN
13 March 2008 Transaction in own shares PRN
7 March 2008 Transaction in own shares PRN
29 February 2008 Transaction in own shares PRN
15 February 2008 Transaction in own shares PRN
14 February 2008 Interim Management Statement PRN
8 February 2008 Transaction in own shares PRN
1 February 2008 Transaction in own shares PRN
25 January 2008 Transaction in own shares PRN
18 January 2008 Transaction in own shares PRN
11 January 2008 Transaction in own shares PRN
9 January 2008 Holdings in Company PRN
4 January 2008 Transaction in own shares PRN
4 January 2008 Portfolio Update PRN
28 December 2007 Transaction in own shares PRN
21 December 2007 Transaction in own shares PRN
14 December 2007 Transaction in own shares PRN
6 December 2007 Transaction in own shares PRN
6 December 2007 Interim Report PRN
16 November 2007 Transaction in own shares PRN
16 November 2007 Interim Results PRN
9 November 2007 Transaction in own shares PRN
8 November 2007 Directorate Change PRN
30 October 2007 Transaction in own shares PRN
26 October 2007 Transaction in Own Shares PRN
11 October 2007 Transaction in Own Shares PRN
3 October 2007 Portfolio Update PRN
2 October 2007 Transaction in Own Shares PRN
1 October 2007 Compliance with Model Code PRN
27 September 2007 Transaction in Own Shares PRN
27 September 2007 Holdings in Company PRN
26 September 2007 Transaction in Own Shares PRN
17 September 2007 Transaction in Own Shares PRN
14 September 2007 Transaction in Own Shares RNS
8 August 2007 Interim Management Statement PRN
8 August 2007 Director declaration PRN
Filings at Companies House
During the year the following documents were filed at Companies House:
Date Document Number Description
28 July 2008 288c Director change of address
7 July 2008 G169 Transaction in own shares
1 July 2008 G169 Transaction in own shares
30 June 2008 G169 Transaction in own shares
26 June 2008 Annual Accounts Annual Report & Accounts
19 June 2008 363s Annual Return
2 June 2008 G169 Transaction in own shares
30 May 2008 G169 Transaction in own shares
7 March 2008 G169 Transaction in own shares
15 February 2008 G169 Transaction in own shares
28 January 2008 G169 Transaction in own shares
7 December 2007 G169 Transaction in own shares
14 November 2007 288b Resignation of a Director
29 October 2007 G169 Transaction in own shares
3 September 2007 G169 Transaction in own shares
23 August 2007 288c Director change of address
16 August 2007 G169 Transaction in own shares
Inspection of Documents
The Company publishes the following documents on its website at
www.biotechgt.com
Annual Report
Interim Report
Interim Management Statement
Monthly Fact Sheets
Copies of certain documents that are required to be lodged at the FSA in
accordance with the Listing Rules, Prospectus Rules and Disclosure Rules are
available for inspection at the following address:
Financial Services Authority
25 The North Colonnade
Canary Wharf
London
E14 5HS
Tel: 020 7676 1000
Copies of documents filed at Companies House are available from:
Registrar of Companies
Companies House
Crown Way
Cardiff
CF14 3UZ
Tel: 0870 3333 636
They may also be downloaded from the website at www.directcompanieshouse.gov.uk
Further information may be obtained from:
Mark Pope
Tel. 020 3008 4913
Frostrow Capital
Fax. 020 3043 8889
25 Southampton Buildings
London
WC2A 1AL
Company Secretary
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.